A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4943-4951

  Carson, William E ^a   Yu, Haixin ^a   Dierksheide, Julie ^a   Pfeffer, Klaus ^b   Bouchard, Page ^c   Clark, Reed ^d   Durbin, Joan ^d   Baldwin, Albert S ^e   Peschon, Jacques ^f   Johnson, Philip R ^d   Ku, George ^g   Baumann, Heinz ^h   Caligiuri, Michael A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c PFIZER INC   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f AMGEN INC   (United States)

^g VERTEX PHARMACEUTICALS   (United States)

^h ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NITRIC OXIDE SYNTHASE; PERFORIN; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FUNCTION; FEMALE; GASTROINTESTINAL DISEASE; IMMUNOPATHOGENESIS; LUNG EDEMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; CELL SEPARATION; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKINS; KILLER CELLS, NATURAL; LIVER; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; MONOCYTES; SHOCK, SEPTIC; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033561555     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Bancroft, G. J. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5:503.
2. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced Interferon γ in defense against marine cytomegalo-virus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045.
3. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
4. Ahn, H. J., S. Maruo, M. Tomura, J. Mu, T. Hamaoka, K. Nakanishi, S. Clark, M. Kurimoto, H. Okamura, and H. Fujiwara. 1997. A mechanism underlying synergy between 1L-12 and IFN-γ-inducing factor in enhanced production of IFN-γ. J. Immunol. 159:2125.
5. Chan, S. H., B. Perusia, J. W. Gupta, M. Kobayashi, M. Popisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
6. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin-15 is a novel cytokine which activates human natural killer cells via components of the interleukin-2 receptor. J. Exp. Med. 180:1395.
7. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578.
8. Bluman, E., K. J. Bartynski, B. R. Avalos, and M. A. Caligiuri. 1996. Human natural killer cells produce abundant macrophage inflammatory protein-1α in response to monocyte-derived cytokines. J. Clin. Invest. 97:2722.
9. Hack, C. E., L. A. Aarden, and L. G. Thijs. 1997. Role of cytokines in sepsis. Adv. Immunol. 66:101.
10. Anderson, D. A., S. Kumaki, M. Ahdieh, J. Bertles, M. Tometsko, A. Loomis, J. Giri, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, V. Valentine, D. N. Shapiro, S. W. Morris, L. S. Park, and D. Cosman. 1995. Functional characterization of the human interleukin-15 receptor chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270:29862.
11. Wigginton, J. M., K. L. Komschlies, T. C. Back, J. L. Franco, M. J. Brunda, and R. H. Wiltrout. 1996. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. Natl. Cancer Inst. 88:38.
12. Ross, M. E., and M. A. Caligiuri. 1997. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89:1910.
13. Su, H. C., R. Ishikawa, and C. A. Biron. 1993. Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J. Immunol. 151:4874.
14. Mohler, K. M., D. S. Torrance, C. A. Smith, R. G. Goodwin, K. E. Stremler, V. P. Fung, H. Madain, and M. B. Widmer. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548.
15. Baiocchi, R. A., and M. A. Caligiuri. 1994. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferalive disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 91:5577.
16. Salazar-Mather, T. P., R. Ishikawa, and C. A. Biron. 1996. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J. Immunol. 157:3054.
17. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkemagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
18. Wang, B., C. Biron, J. She, K. Higgins, M. J. Sunshine, E. Lacy, N. Lonberg, and C. A. Terhorst. 1994. Block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc. Natl. Acad. Sci. USA 91:9402.
19. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
20. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
21. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrisey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943.
22. Glaccum, M. B., K. L. Stocking, K. Charrier, J. L. Smith, C. R. Willis, C. Maliszewski, D. J. Livingston, J. J. Peschon, and P. J. Morrissey. 1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159:3364.
23. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishira, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
24. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1α for an inflammatory response to viral infection. Science 269:1583.
25. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q.-W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641.
26. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000.
27. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat 1 gene results in compromised innate immunity to viral disease. Cell 84:443.
28. Goldblum, S. E., M. Jay, K. Yoneda, D. A. Cohen, C. J. McClain, and M. N. Gillespie. 1987. Monokine-induced lung injury in rabbits. J. Appl. Physiol. 63:2093.
29. Fehniger, T. A., W. E. Carson, E. Mrozek, and M. A. Caligiuri. 1997. Stem cell factor enhances interleukin-2-mediated expansion of murine natural killer cells in vivo. Blood 90:3647.
30. Lai, C. F., J. Ripperger, K. K. Morella, J. Jurlander, T. S. Hawley, W. E. Carson, T. Kordula, M. A. Caligiuri, R. Hawley, G. H. Fey, and H. Baumann. 1996. Receptors for IL-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J. Biol. Chem. 271:13969.
31. Iimuro, Y., T. Nishiura, C. Hellerbrand, K. E. Betons, R. Schoonhoven, J. W. Grisham, and D. A. Brenner. 1998. NFκB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101:802.
32. Rose, J. A., K. I. Berns, M. D. Hoggan, and F. J. Koczot. 1969. Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proc. Natl. Acad. Sci. USA 64:863.
33. Gin, J. G., S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L. S. Park, and D. M. Andersen. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14:3654.
34. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutant in the mouse. Nature 301:527.
35. Mattory, Y. L., A. E. Chang, E. H. Lipford, R. Braziel, C. L. Hyatt, H. D. McDonald, and S. A. Rosenberg. 1985. Toxicity of recombinant human interleukin-2 in rats following intravenous infusion. J. Biol. Response Modif. 4:377.
36. Trinchieri, G. 1994. Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T helper cells type I and cytotoxic lymphocytes. Blood 84:4008.
37. Gauldie, J., and H. Baumann. 1991. Cytokines and acute phase protein expression. In Cytokines and Inflammation. E. S. Kimball, ed. CRC Press, Boca Raton, p. 275.
38. Dinarello, C. A. 1996. Cytokines as mediators in the pathogenesis of septic shock. Curr. Top. Microbiol. Immunol. 216:134.
39. Sadowski, H. B., K. Shuai, J. E. Darnell, and M. Z. Gilman. 1993. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739.
40. Kumar, A., M. Commane, T. W. Flickinger, C. M. Horvath, and G. R. Stark, 1997. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278:1630.
41. Theodos, C. M., K. L. Sullivan, J. K. Griffiths, and S. Tzipori. 1997. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of γ interferon modulation determines the outcome of infection. Infect. Immun. 65:4761.
42. Papa, M. Z., J. T. Vetto, S. E. Ettinghausen, J. J. Mule, and S. A. Rosenberg. 1986. Effects of corticosleroids on antitumor activity of lymphokine-activated killer cells and interleukin-2 in mice. Cancer Res. 46:5618.
43. Yamamoto, H., M. Hirayama, C. Genyea, and J. Kaplan. 1994. TGF-β mediates natural suppressor activity of IL-2-activated lymphocytes. J. Immunol. 152:3842.
44. Eberlein, T. J., D. D. Schoof, H. R. Michie, A. F. Massaro, U. Burger, D. W. Wilmore, and R. E. Wilson. 1989. Ibuprofen causes reduced toxic effects of interleukin 2 administration in patients with metastatic cancer. Arch. Surg. 124:542.
45. Bohrer, H., F. Qiu, T. Zimmerman, Y. Zhang, T. Jllmer, D. Mannel, B. W. Bottiger, D. M. Stern, R. Waldhen, H.-D. Saeger, R. Zeigler, A. Bierhaus, E. Martin, and P. P. Nawroth. 1997. Role of NFκB in the mortality of sepsis. J. Clin. Oncol. 100:972.
46. Wang, C. Y., M. W. Mayo, and A. S. Baldwin Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784.
47. Frederica, C., M. Forni, C. Riccardi, A. Soleti, F. Di Pierro, and G. Forni. 1992. Growth and spread of human malignant T lymphoblasts in immunosuppressed nude mice: a model for meningeal leukemia. Blood 80:1279.
48. Trinchieri, G., M. Kubin, G. Bellone, and M. C. Cassatella. 1993. Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. J. Cell. Biochem. 7:145.
49. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med 174:1549.
50. Damas, P., D. LeDoux, M. Nijs, Y. Vrindts, D. De Groote, P. Franchimont, and M. Lamy. 1992 Cytokine serum levels during severe sepsis in humans: IL-6 as a marker of severity. Ann. Surg. 215:356.
51. Dietch, E. A. 1992. Multiple organ failure: pathophysiology and potential future therapy. Ann. Surg. 216:117.
52. Mier, J. W. 1993. Pathogenesis of interleukin-2-induced vascular leak syndrome. In Therapeutic Applications of Interleukin-2. M. B. Atkins and J. W. Mier, eds. Marcel Dekker, New York, p. 363.
53. Leonard, J. P., M. L. Sherman, G. L. Fisher, L. J. Buchanan, G. Karsen, M. B. Atkins, J. A. Sosman, J. P. Dutcher, N. J. Vogelzang, and J. L. Ryan. 1997. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-γ production. Blood 90:2541.
54. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
55. Wu, C. Y., R. R. Warrier, D. M. Carvajal, A. O. Chu, L. J. Minetti, R. Chizzonite, P. K. Mongini, A. S. Stern, U. Gubler, D. H. Presky, and M. K. Gately. 1996. Biological function and distribution of human interleukin-12 receptor β chain. Eur. J. Immunol. 26:345.
56. Unanue, E. R. 1996. Macrophages, NK cells and neutrophils in the cytokine loop of Listeria resistance. Res. Immunol. 147:499.
57. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyle-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
58. Heremans, H., J. Van Damme, C. Dillen, R. Dijkmans, and A. Billiau. 1990. Interferon γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171:1853.
59. Heremans, H., C. Dillen, J. van Damme, and A. Billiau. 1994. Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice. Eur. J. Immunol. 24:1155.
60. Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, and G. Garotta 1994. Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180:907.
61. Ortaldo, J. R., A. Mason, and J. J. O'Shea. 1995. Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med. 181:339.
62. Eischen, C. M., J. D. Schilling, D. H. Lynch, P. H. Krammer, and P. J. Leibson. 1996. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 156:2693.
63. Ida, H., M. J. Robertson, S. Voss, J. Ritz, and P. Anderson. 1997. CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. J. Immunol. 159:2154.
64. Yamauchi, A., K. Taga, H. S. Mostowski, and E. T. Bloom. 1996. Target cell-induced apoptosis of interleukin-2-activated human natural killer cells: roles of cell surface molecules and intracellular events. Blood 87:5127.
65. Van Parijs, L., and A. K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280:243.
66. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Kramer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91.
67. Chatenoud, L. 1993. OKT3-induced cytokine-release syndrome: prevention effect of anti-tumor necrosis factor monoclonal antibody. Transplant. Proc. 25:47.